Selvita agreed a unit merger plan affecting Selvita stock

Published on 10/20/2026 at 12:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The September 30, 2026 plan combines two wholly owned units without new shares. Selvita stock costs EUR 4.19 on October 20, 2026.

Merger plan and operating scale

Selvita's wholly owned units signed a merger plan on September 30, 2026.
The transaction covers 2 subsidiaries and requires no new shares.
Selvita stock trades at EUR 4.19 at 12:21 p.m. CEST at Lang & Schwarz on October 20, 2026.
Selvita had a PLN 337.7 million market capitalization on October 20, 2026.

Selvita, PLSLVCR00029, Illustration mit AI erstellt.

Selvita (PLSLVCR00029) had agreed a plan to merge two wholly owned subsidiaries, putting internal structure and operating efficiency at the center of the latest Selvita stock story. According to Bankier.pl, the boards of Selvita Services and PozLab signed the merger plan on September 30, 2026.

Why simplify two units?

The proposed transaction covers 2 subsidiaries that are both fully owned by Selvita. The merger is structured without a capital increase or new shares, while Selvita Services would take over PozLab's assets, liabilities, rights and obligations once the transaction is registered.

The filing describes 3 operating aims: simplifying the group structure, streamlining internal processes and using synergies more fully in drug development services. It also points to lower costs from running 2 parallel entities and a unified brand for marketing and sales. According to BiznesRadar.pl, the merger would not change the group's consolidated financial statements because both subsidiaries are already fully consolidated.

Three steps since September 30

On September 30, 2026, Selvita Services and PozLab agreed and signed the merger plan. On October 1, 2026, Selvita published the current report covering the transaction and its simplified legal procedure, according to Bankier.pl. On October 2, 2026, Selvita registered a charter change, according to GPW Alert.

What does the valuation show?

Selvita's market capitalization was PLN 337.7 million on October 20, 2026, while its Warsaw Stock Exchange price was PLN 18.40 at 10:10 a.m. UTC on the same date. The 52-week range stood at PLN 18.30 to PLN 49.40, placing the quoted price close to the lower end of that band.

Stock price and structure

The merger plan is an efficiency measure rather than a new share issue, so its immediate significance lies in simplifying the operating platform. Selvita's business spans contract research, drug discovery and development support for pharmaceutical and biotechnology customers.

Selvita stock was trading at EUR 4.19 at Lang & Schwarz on October 20, 2026 at 12:21 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Selvita stock.